Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

451

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

451 results for “Angiogenesis”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov32/100

Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy

ClinicalTrials.gov study NCT02790541. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial

ClinicalTrials.gov study NCT00620217. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

ClinicalTrials.gov study NCT03809689. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Endothelial Damage and Angiogenesis Biomarkers During COVID-19

ClinicalTrials.gov study NCT04609332. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
dryad32/100

Comparative analysis of angiogenesis models: MATLAB data files

Open the record for dataset details and reuse information.

publicJan 2021View details →
dryad32/100

Enhanced stromal H2S production via CBS upregulation promotes estrogen-stimulated human endometrial angiogenesis

Open the record for dataset details and reuse information.

publicAug 2020View details →
zenodo28/100

Therapeutic Potential of the Laminin-1-Derived Peptide C16 in Interactions with αvβ3 and α5β1 Integrins: In Silico Analysis and Implications for Angiogenesis, Cancer, and Tissue Regeneration

<p>Molecular Dynamics<br><br>Molecular Docking there has also been performed molecular dynamics simulation studies by GROMACS 2023 to study the relationship between structure and function and properties by the analysis of molecular conformation sampling (cluster analysis, dominant conformation identification), interaction analysis (hydrogen bonding network, Contact-Map, Binding free energy calculations (MM-PBSA), backbone fluctuation analysis (RMSD, RMSF), Conformational transition analysis (simple normal mode analysis, dominant conformation identification), and physicochemical property analysis (energy, volume, pressure, temperature, density monitoring) (Luzik et al., 2019; Zhang et al., 2003).</p> <p>For simulation purposes, a simulation system was set up for the protein-ligand complex with solvent using GPU-enabled GROMACS 2024.2 package (Abraham et al., 2024). The &alpha;v&beta;3 and &alpha;5&beta;1 in water simulation were performed with GROMACS standard protocols also, &alpha;v&beta;3_S1@C16, &alpha;v&beta;3_S2@C16, &alpha;5&beta;1@C16 complex, and &alpha;v&beta;3, &alpha;v&beta;3 proteins MD simulation was carried out in triplicate. All necessary topology files were generated using CHARMM-GUI (Lee et al., 2016; Park et al., 2023).&nbsp;<br>CHARMM-GUI was used to build the simulation system (Allouche, 2012). And provided scripts compatible with GROMACS&nbsp; (Lee et al., 2016), provideding TIP3P water model to solvate the system.</p> <p>The dimensions of the box were defined by ensuring at least a 10 &Aring; distance between the protein and the box edges to avoid boundary effects. Proper neutralization of the system was achieved by adding counterions (Na+ and Cl&minus;) based on the protein&rsquo;s charge automatically calculated by CHARMM-GUI. CHARMM36 force field was chosen, which provides parameters for proteins and peptides. Before the production MD simulation, energy minimization was performed to remove any unfavorable contacts or steric clashes in the system. CHARMM-GUI The system was equilibrated in two stages. First, the system was equilibrated under an NVT ensemble (constant number of particles, volume, and temperature) with restraints applied to the heavy atoms of the protein to allow the water and ions to relax around the solute. This phase runs for 100 ps. Second, the restraints were removed, and the system was equilibrated under an NPT ensemble (constant number of particles, pressure, and temperature) for an additional 1 ns to stabilize the density of the system (Galmozzi et al., 2014; K. W. Wang et al., 2022).</p> <p>The minimization, equilibration, and production steps were performed using the GROMACS 2024.2 The steepest-descent energy minimization was used, and the maximum force was set to 100 kJ/(mol∙nm) on any atom. The solvated system was equilibrated with two steps. First, the system was equilibrated for 1 ns under a constant volume ensemble (NVT) without restraints applied. Second, the system was equilibrated for another 1 ns under a constant pressure ensemble (NPT) without any restraint. Production simulation was conducted for 100 ns under the NPT ensemble. All bonds containing hydrogen atoms were constrained using the default LINCS constraint algorithm. The coupling algorithm of Nose-Hoover was used to maintain temperature (310 K) and Parrinello-Rahman algorithm to maintain temperature pressure (1 atm, 101 325 Pa) with a constant of 1.0 ps. The electrostatic interactions were treated with the particle mesh-Ewald (PME) method. The integration time step was set to 2 fs and periodic boundary conditions were applied in all directions (Bansal et al., 2021; H. Yu et al., 2015).&nbsp;</p> <p>2.4.1. MMPBSA analyses&nbsp;<br>GROMACS modules gmx rms for root mean square deviation (RMSD), gmx rmsf for root mean square fluctuation (RMSF), gmx hbond for numbers of hydrogen-bond (Hbond), gmx gyrate for the radius of gyration (Rg), gmx sasa for solvent accessible surface area (SASA) were used to analyze each complex system. The xmgrace module was employed to generate plots and graphs to represent binding energies, interaction frequencies, and structural changes. The Molecular Mechanics/Poisson-Boltzmann Surface Area (MM-PBSA) binding free energies like van der Waals and electrostatic interactions, potential energy, polar, and non-polar solvation energies were calculated by gmx_MMPBSA a tool based on AMBER's MMPBSA.py aiming to perform end-state free energy calculations with GROMACS files (Vald&eacute;s-Tresanco et al., 2021). It has employed the visualization tools VMD and PyMOL to examine the trajectory and interaction details.</p> <p>References:</p> <p>Allouche, A. (2012). Software News and Updates Gabedit &mdash; A Graphical User Interface for Computational Chemistry Softwares. Journal of Computational Chemistry, 32, 174&ndash;182. https://doi.org/10.1002/jcc.</p> <p>Galmozzi, A., Dominguez, E., Cravatt, B. F., &amp; Saez, E. (2014). CHARMM-GUI Ligand Binder for Absolute Binding Free Energy Calculations and Its Application. Methods Enzymol., 538(1), 151&ndash;169.</p> <p>Bansal, R., Mohagaonkar, S., Sen, A., Khanam, U., &amp; Rathi, B. (2021). In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid protein. In Silico Pharmacology, 9(1), 1&ndash;14. https://doi.org/10.1007/s40203-021-00103-z.</p> <p>Park, S. J., Kern, N., Brown, T., Lee, J., &amp; Im, W. (2023). CHARMM-GUI PDB Manipulator: Various PDB Structural Modifications for Biomolecular Modeling and Simulation. Journal of Molecular Biology, 435(14), 167995. https://doi.org/10.1016/j.jmb.2023.167995.</p> <p>Lee, J., Cheng, X., Swails, J. M., Yeom, M. S., Eastman, P. K., Lemkul, J. A., Wei, S., Buckner, J., Jeong, J. C., Qi, Y., Jo, S., Pande, V. S., Case, D. A., Brooks, C. L., MacKerell, A. D., Klauda, J. B., &amp; Im, W. (2016). CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. Journal of Chemical Theory and Computation, 12(1), 405&ndash;413. https://doi.org/10.1021/acs.jctc.5b00935.&nbsp;</p> <p>Luzik, D. A., Rogacheva, O. N., Izmailov, S. A., Indeykina, M. I., Kononikhin, A. S., &amp; Skrynnikov, N. R. (2019). Molecular Dynamics model of peptide-protein conjugation: case study of covalent complex between Sos1 peptide and N-terminal SH3 domain from Grb2. Scientific Reports, 9(1), 1&ndash;18. https://doi.org/10.1038/s41598-019-56078-7.</p> <p>Vald&eacute;s-Tresanco, M. S., Vald&eacute;s-Tresanco, M. E., Valiente, P. A., &amp; Moreno, E. (2021). gmx\_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. Journal of Chemical Theory and Computation, 17(10), 6281&ndash;6291. https://doi.org/10.1021/acs.jctc.1c00645.</p> <p>Wang, K. W., Lee, J., Zhang, H., Suh, D., &amp; Im, W. (2022). CHARMM-GUI Implicit Solvent Modeler for Various Generalized Born Models in Different Simulation Programs. Journal of Physical Chemistry B, 126(38), 7354&ndash;7364. https://doi.org/10.1021/acs.jpcb.2c05294.&nbsp;</p> <p>Yu, H., Wang, M. jun, Xuan, N. xia, Shang, Z. cai, &amp; Wu, J. (2015). Molecular dynamics simulation of the interactions between EHD1 EH domain and multiple peptides. Journal of Zhejiang University: Science B, 16(10), 883&ndash;896. https://doi.org/10.1631/jzus.B1500106.&nbsp;</p> <p>Zhang, Z., Shi, Y., &amp; Liu, H. (2003). Molecular dynamics simulations of peptides and proteins with amplified collective motions. Biophysical Journal, 84(6), 3583&ndash;3593. https://doi.org/10.1016/S0006-3495(03)75090-5.&nbsp;</p>

opencc-by-4.0Nov 2024View details →
ClinicalTrials.gov28/100

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

ClinicalTrials.gov study NCT01321437. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image

ClinicalTrials.gov study NCT00172562. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake

ClinicalTrials.gov study NCT00671242. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia

ClinicalTrials.gov study NCT07065682. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

ClinicalTrials.gov study NCT00094094. IPD Sharing: Not stated. Countries: 2. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell

ClinicalTrials.gov study NCT00518934. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis

ClinicalTrials.gov study NCT00565721. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Neo-angiogenesis in Inguinal Henia Implant ProFlor

ClinicalTrials.gov study NCT04541316. IPD Sharing: YES. Countries: 0. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

The Inflammatory Response to Stress and Angiogenesis in Liver Resection

ClinicalTrials.gov study NCT03131778. IPD Sharing: NO. Countries: 0. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

ClinicalTrials.gov study NCT00094107. IPD Sharing: Not stated. Countries: 2. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies

ClinicalTrials.gov study NCT03387514. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo24/100

Diabetic Kidney Disease Induces Transcriptome Alterations Associated with Angiogenesis Activity in Human Mesenchymal Stromal Cells [mRNA]

GEO Series GSE217709. Homo sapiens. 38 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2023View details →
geo24/100

Regulation of Angiogenesis by EZH2

GEO Series GSE20381. Homo sapiens. 12 samples. Type: Expression profiling by array.

openGEO-OpenOct 2010View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record